Lavreysen; Hilde

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lavreysen; Hilde.The latest application filed is for "combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use".

Company Profile

3.5.7

Lavreysen; Hilde - Lommel BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use Grant 11,369,606 - Klein , et al. June 28, 2	2022-06-28
Combinations Comprising Positive Allosteric Modulators Or Orthosteric Agonists Of Metabotropic Glutamatergic Receptor Subtype 2 And Their Use App 20220143141 - KLEIN; Brian D. ; et al.	2022-05-12
Combinations Comprising Positive Allosteric Modulators Or Orthosteric Agonists Of Metabotropic Glutamatergic Receptor Subtype 2 And Their Use App 20220047593 - KLEIN; Brian D. ; et al.	2022-02-17
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use Grant 11,103,506 - Klein , et al. August 31, 2	2021-08-31
Combinations Comprising Positive Allosteric Modulators Or Orthosteric Agonists Of Metabotropic Glutamatergic Receptor Subtype 2 App 20200138813 - KLEIN; Brian D. ; et al.	2020-05-07
Combinations Comprising Positive Allosteric Modulators Or Orthosteric Agonists Of Metabotropic Glutamatergic Receptor Subtype 2 App 20200138814 - KLEIN; Brian D. ; et al.	2020-05-07
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use Grant 10,537,573 - Klein , et al. Ja	2020-01-21
1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors Grant 9,708,315 - Cid-N nez , et al. July 18, 2	2017-07-18
Combinations Comprising Positive Allosteric Modulators Or Orthosteric Agonists Of Metabotropic Glutamatergic Receptor Subtype 2 And Their Use App 20160367554 - KLEIN; Brian D ; et al.	2016-12-22
1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS App 20160194318 - Cid-N nez; Jose Maria ; et al.	2016-07-07
Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands Grant 7,517,517 - Lesage , et al. April 14, 2	2009-04-14
Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands App 20060083676 - Lesage; Anne Simone Josephine ; et al.	2006-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.